Biodesix: New clinical findings show diagnostic advances for novel drug

Biodesix: New clinical findings show diagnostic advances for novel drug

BOULDER -- Biodesix Inc . announced new clinical findings that show its novel investigational test, BDX008 based on profiling serum proteins identifies patients with advanced melanoma who are... Read More

Tuesday November 10, 2015 0 comments Tags: Boulder, Biodesix, Richard Hockett, melanoma, nivolumab